Asarabacca

Asarabacca (Asarum europaeum L.): A Comprehensive Reference

1. Identity, Botanical Classification, and Natural Source

Botanical name: Asarum europaeum L. The species was formally described by Carl Linnaeus in his Species Plantarum in 1753. Linnaeus established the genus Asarum in that work, describing four initial species and designating Asarum europaeum as the type species.

Common names: Asarabacca, Hazlewort, Wild nard. Other names include false coltsfoot, snakeroot, wild ginger, hasselurt (Danish), Haselwurz (German), asaro (Spanish), and asaret d'Europe (French).

Etymology: The genus name Asarum derives from the ancient Greek ásaron, a term used by Dioscorides and Pliny the Elder for this or a similar plant, reflecting its historical recognition in classical botany. The composite name "asarabacca" has a curious linguistic history: Dioscorides described the plant precisely in his De Materia Medica under the name "Asaron." He also wrote of a bacchareis, which some herbalists took to be Asarum europaeum as well, though the two descriptions do not tally. Virgil in the Eclogues wrote of a baccar which grew with ivy in the way of A. europaeum. As if to compromise and resolve the matter, apothecaries squashed the two names into one to give the strange word "Asarabacca."

Family and classification: Asarabacca belongs to the Aristolochiaceae, or the birthwort family. At the time of Linnaeus, Asarum was classified under the Aristolochiaceae family, commonly known as the birthwort family, due to the peculiar shapes of flowers in related genera that evoked ancient associations with childbirth and herbal remedies.

Morphology and habitat: Asarabacca is a perennial plant that can reach a height of 10–15 cm (4 to 6 inches). It has creeping and branching rhizomes and dark green, shiny 5–10 cm wide leaves. Flowering occurs between May and June, and the bell-shaped flowers have three broad petals that are reddish-brown. Asarum europaeum has a wide distribution in Europe. It ranges from southern Finland and northern Russia south to southern France, Italy, the former Yugoslavia, and Bulgaria. It is absent from the British Isles and Scandinavia, and also from northwestern Germany and the Netherlands. It occurs mostly in deciduous woodland or coniferous forests, especially in calcareous (chalky) soils.

Plant parts used medicinally: The rhizome and leaves of Asarum europaeum are the principal parts used. The root is harvested in the spring and dried for later use. The root is ash-colored, 2 or 3 lines in thickness, 4-angled, contorted, rough; it has a pepper-like odor, a biting, spicy taste, and yields an ash-colored powder.

2. Traditional and Historical Use

2.1 Ancient Greek and Roman Traditions

Asarabacca has a long history of herbal use dating back at least to the time of the ancient Greeks, though it is little used in modern herbalism. According to Dioscorides, the name asaron can be translated from ancient Greek as "disgust, discomfort," alluding to the vomit-inducing property of the plant.

2.2 European Medieval and Early Modern Use

During the Middle Ages, Asarum europaeum was used for its laxative, diuretic, and emetic properties. Indeed, asarum was the primary herbal remedy for poisoning due to food and mushrooms until ipecacuanha (Cephaelis ipecacuanha) was introduced to Europe in the 1600s. Until ipecacuanha was introduced — a plant from South America with emetic properties but fewer side effects — asarabacca was the main remedy for food or mushroom poisoning, though its toxicity likely did more harm than good.

In former days, it was used in snuff and also medicinally as an emetic and cathartic. In moderate doses, not exceeding a few grains, snuffed up the nose several successive evenings, it was reported to produce a copious watery discharge which sometimes continued for several days together, by which headache, toothache, ophthalmia, and some paralytic and soporific complaints were reportedly relieved. As an errhine, one or two grains of the root, or three or four grains of the dried leaves, were snuffed up the nostrils every night. The compound preparation Pulvis Asari Compositus (Compound Powder of Asarabacca), composed of dried asarabacca leaves and lavender flowers reduced to powder, was used as an errhine in headache and ophthalmia.

In the past, the herb was used as a treatment for rhinitis, pneumonia, angina pectoris, migraine, liver diseases, and jaundice.

2.3 Unani (Greco-Arab) Medicine

In Unani medicine, asaroon is the rhizome of Asarum europaeum L. and is commonly used for its various pharmacological actions. Asaroon has attributed actions including Muharrik-i-A'sab (nervine stimulant), Mudirr-i-Bawl (diuretic), Mudirr-i-Hayd (emmenagogue), Musakkin-i-Alam (analgesic), Mufattit-i-sudad (remove obstructions), and Muqawwī-i-Jigar (hepatotonic). It is used in the management of fevers, polyarthritis, epilepsy, paralysis, amenorrhea, and gout. In Unani medicine, A. europaeum has traditionally been utilized to treat respiratory ailments, gastrointestinal disorders, neurological diseases, hepatic disorders, genitourinary disorders, snake poisoning, vector-borne infections, and for epidemic prophylaxis.

2.4 Use in Homeopathy

Before Hahnemann's time, asarum was primarily recognized as an emetic. Samuel Hahnemann incorporated it into the homeopathic materia medica in the early 19th century. The preparation of Asarum europaeum in homeopathy follows the standard principles of homeopathic pharmacopeia: the fresh root and rhizome are harvested, cleaned, and finely chopped, then macerated in alcohol to create a mother tincture. The tincture undergoes serial dilution and succussion (vigorous shaking) to produce various potencies denoted by numbers and letters such as 6C, 30C, or 200C, indicating the degree of dilution. In Europe, Asarum europaeum L. is used in homeopathic tinctures.

2.5 Traditional Chinese Medicine Context

While A. europaeum is not the primary species used in Traditional Chinese Medicine (TCM), it belongs to the same genus as the TCM medicinal herb Xixin. Crude drug from several medicinal plants of genus Asarum, known as Asari Radix et Rhizoma (ARR), has been proven to have the functions of dispelling cold, relieving pain, and reducing phlegm according to TCM theory for thousands of years. In Oriental Materia Medica, it is said that asarum "dispels cold and wind, warms the lungs to resolve accumulated fluids." The indications are: "sinusitis, toothache, rheumatoid arthritis due to wind and dampness, retention of phlegm and fluid, cough with dyspnea, general coughing."

3. Key Constituents and Active Compounds

3.1 Essential Oil

The rootstock of the plant contains resin, starch, tannins, flavonoids, aristolochic acid, and up to 4% essential oil. The essential oil contains a variety of substances, principally asarone (approximately 30%), methyleugenol (approximately 20%), and bornyl acetate (approximately 15%). Known constituents of the volatile oil also include asarone, pinene, and eugenol methyl ether.

Phytochemical analysis from various sections of the plant reveals the presence of essential oils with four distinct chemotypes, flavonoids, phenolic compounds, organic acids, vitamins, terpenes, and sesquiterpenes.

3.2 Asarone Isomers

Asarone — specifically its α and β isomers — is among the most pharmacologically active and toxicologically significant compounds in the genus. Asarone isomers such as β-asarone can constitute up to 70% of the essential oil in certain chemotypes and possess local anesthetic effects. Both alpha and/or beta-asarone possess an extensive array of pharmacological effects in preclinical models, including antioxidant, anti-inflammatory, antidepressant, anxiolytic, anti-Alzheimer's, anti-Parkinson's, antiepileptic, anticancer, antihyperlipidemic, antithrombotic, anticholestatic, and radioprotective activities. These pharmacological activities are predominantly based on preclinical (in vitro and animal) data, not confirmed human clinical trials.

Regarding neuropharmacology, β-asarone is reported to cross the blood-brain barrier and possesses beneficial effects on the central nervous system and cardiovascular system. It has shown beneficial effects in experimental models of diseases such as Alzheimer's disease, cerebral ischemia, and epilepsy. Separately, α-asarone is reported to possess anti-epileptic and hypolipidemic properties in preclinical models.

3.3 Aristolochic Acids

Aristolochic acids (AAs) are a group of toxins commonly present in the plants of genus Aristolochia and Asarum, which are spread all over the world. LC-MS profiles reveal variability in these compounds across plant parts and chemotypes; AA-I is detected in trace amounts (higher in aerial parts than roots) in A. europaeum samples, while aristolactam I concentrations are elevated in rhizomes.

3.4 Phenylpropanoids and Other Alkenylbenzenes

The plant contains a rich mixture of volatile (essential) oils, phenylpropanoids (alkenylbenzenes), lignans and neolignans, amides, flavonoids, and phenolic compounds. Potentially toxic components include safrole, methyl eugenol, aristolochic acids, asarone, 3,5-dimethoxytoluene, and benzene derivatives.

3.5 Flavonoids

Antioxidant flavonoids are present, including quercetin and its glycosides such as quercetin 3-O-galactoside and quercetin 3-O-glucoside, isolated from leaves and roots, which demonstrate free radical scavenging activity.

3.6 Sesquiterpenes

Anti-inflammatory sesquiterpenes including α-agarofuran and furopelargone are also present among the bioactive constituents. Phytochemical investigations of the rhizomes published in Planta Medica in 1979 led to the characterization of the tricyclic α-agarofurane in the essential oil fraction.

4. Documented Mechanisms of Action

4.1 Irritant and Errhine Action

Asarabacca produces nasal irritation, followed by free secretions, which flow persistently. It is emetic, cathartic, and errhine. An essential oil in the root contains asarone and is highly toxic relative to other plant oils; this essential oil is considered the emetic and expectorant principle of the plant.

4.2 Anti-Inflammatory and Analgesic

Essential oils of A. europaeum were tested in rodent inflammatory models, where the oil significantly reduced carrageenan-induced paw edema and writhing response in mice, suggesting anti-inflammatory and analgesic potential. These results are from animal models only and have not been validated in controlled human trials.

4.3 Local Anesthetic Activity

The essential oil contains asarone, which has expectorating, broncholytic, and antibacterial effects and also works as a local anesthetic. Phytochemical research by Gracza (1983) in Planta Medica specifically investigated the local anesthetic activity of phenylpropane derivatives isolated from A. europaeum.

4.4 Antimicrobial Activity

Essential oil from Asarum europaeum has been shown to exert antimicrobial and antioxidant properties and displays high efficacy against pathogenic bacteria and fungi in laboratory settings. Phenylpropanoids from A. europaeum show antimicrobial activity against gram-positive bacteria; in experimental conditions, the methanol extract proved most effective against Staphylococcus species. All such evidence is based on in vitro laboratory assays.

4.5 Neuroprotective Mechanisms (Preclinical)

The in vitro and in vivo neuroprotective effects of both α-asarone and β-asarone have been reported in preclinical models. These effects are thought to involve modulation of cholinergic signaling, inhibition of beta-amyloid aggregation, and reduction of oxidative stress in neural tissue, based on in vitro and rodent studies. No human clinical evidence corroborates these mechanisms for A. europaeum specifically.

5. Scientific Evidence by Area of Use

5.1 Respiratory Conditions

A. europaeum has traditionally been used to treat respiratory ailments including bronchitis. The asarone constituent is reported to have broncholytic and expectorant effects. Ginger and Asarum application by acupoint sticking therapy has been suggested to improve the clinical symptoms of bronchial asthma, though the evidence for this is limited and not derived from rigorously controlled trials specific to A. europaeum alone. The current scientific evidence for respiratory uses is confined to in vitro pharmacology, rodent models, and traditional practice records. No high-quality randomized controlled trials (RCTs) specific to A. europaeum and respiratory conditions have been identified in the peer-reviewed literature.

5.2 Neurological and CNS Applications

The genus Asarum has attracted research interest in neurological contexts because of the CNS activity of its asarone isomers. Preclinical evidence shows β-asarone has beneficial effects in experimental models of Alzheimer's disease, cerebral ischemia, and epilepsy. A 2022 review in Journal of Ethnopharmacology concluded that the therapeutic potential of genus Asarum has been demonstrated with pharmacological effects on inflammation, CNS, respiratory regulation, cardiovascular diseases, cancer, and microbial infection. However, further in-depth studies on mechanism of actions, metabolism, pharmacokinetics, toxicology, drug interactions, and clinical trials are still limited. All neurological evidence for A. europaeum specifically remains preclinical.

5.3 Antimicrobial Activity

Essential oil from Asarum europaeum has been shown to exert antimicrobial and antioxidant properties and displayed high efficacy against pathogenic bacteria and fungi in laboratory evaluation. The evidence is restricted to in vitro assays and should be characterized as preliminary. No clinical trials in humans have evaluated asarabacca for infectious disease indications.

5.4 Anti-inflammatory and Analgesic Applications

Asarum essential oil (AEO) has been shown to have good pharmacological activities for anti-inflammatory and analgesic effects in preclinical models, but increasing the dose may cause toxicity. These observations come from rodent models; no controlled human trials examining the anti-inflammatory or analgesic effects of A. europaeum specifically have been published.

5.5 Anti-Cancer Activity (In Vitro)

Ethanolic extracts of A. europaeum have been evaluated against human cancer cell lines including HL-60 leukemia, KB oral carcinoma, and BGC-823 gastric carcinoma in in vitro settings. The evidence is exclusively in vitro and carries no clinical relevance without confirmatory animal and human data.

5.6 Hepatoprotective Activity

Contemporary pharmacological assessments have documented antioxidant, anti-inflammatory, antimicrobial, hepatoprotective, and neuroprotective properties. The hepatoprotective claim is based on in vitro and animal data; it is counterbalanced by evidence of hepatotoxicity from asarone constituents (see Section 7).

5.7 Emetic and Cathartic Action (Historical Clinical Observation)

Asarabacca produces nasal irritation, followed by free secretions, which flow persistently, and is emetic, cathartic, and errhine. These properties were clinically observed and documented in historical pharmacopoeias and early clinical literature, representing the oldest form of documented human use. However, these uses have been displaced by safer agents and are no longer pursued in contemporary medicine.

5.8 Unani-Documented Clinical Uses

A. europaeum has been evaluated through in vitro, in vivo, in silico, preclinical, and some clinical trial models for diverse pharmacological activities including antibacterial, anti-diabetic, and anti-proliferative activities. The ScienceDirect review article on Unani medicine (2022) represents the most comprehensive modern compilation of evidence, though most cited studies are in vitro or animal-based. Robust, independently replicated RCTs confirming efficacy for any specific indication in humans are absent from the current literature.

6. Body Systems and Health Areas of Association

• Respiratory system: Traditionally utilized to treat respiratory ailments including bronchitis and cough.
• Gastrointestinal system: Used as a laxative, diuretic, and emetic agent.
• Nervous system / CNS: Used principally as an errhine in certain affections of the brain, eyes, face, and throat, toothache, ophthalmia, and paralysis of the mouth and tongue.
• Urinary system: Classified in Unani medicine as a diuretic (Mudirr-i-Bawl).
• Reproductive system: Described as an emmenagogue (Mudirr-i-Hayd) in Unani medicine.
• Musculoskeletal system: Used in the management of polyarthritis and gout in the Unani tradition.
• Hepatic system: Classified as a hepatotonic (Muqawwī-i-Jigar) in Unani medicine.
• Sensory organs: Used in the treatment of affections of the brain, eyes, throat, and mouth.

7. Dosage Forms and Reported Preparations

Usage has been well documented in the form of powder, decoction, syrup, extract, and oil, as a single drug or in compound formulations with the amalgamation of other herbs.

Historical dosing as an errhine (snuff): As an emetic, the historical dose was half a drachm to a drachm. As an errhine, one or two grains of the root, or three or four grains of the dried leaves, were snuffed up the nostrils every night.

Compound preparations: The Pulvis Asari Compositus (Compound Powder of Asarabacca) — composed of dried asarabacca leaves and lavender flowers — was used as an errhine in headache and ophthalmia.

Homeopathic preparations: In homeopathy, the fresh root and rhizome are macerated in alcohol to create a mother tincture. The tincture undergoes serial dilution and succussion to produce various potencies. In Europe, Asarum europaeum L. is used in homeopathic tinctures.

Unani Pharmacopoeia: The rhizome (Asaroon) is used in Unani medicine as listed in the Unani Pharmacopoeia of India.

No specific dosage figures from modern clinical trials are available in the literature for any oral, topical, or inhaled preparations of A. europaeum as a contemporary dietary supplement. All dosage information in the literature relates either to historical pharmacopoeial practice or to toxicological safety assessments.

8. Safety Considerations and Regulatory Status

8.1 Aristolochic Acid Nephropathy and Carcinogenicity

Aristolochic acids are a family of carcinogenic, mutagenic, and nephrotoxic phytochemicals commonly found in the flowering plant family Aristolochiaceae (birthworts). Since the 1990s, AA-induced nephropathy (AAN) and upper tract urothelial carcinoma (UTUC) have been reported in many countries. The underlying mechanisms of AAN and AA-induced UTUC have been extensively investigated. AA-derived DNA adducts are recognized as specific biomarkers of AA exposure, and a mutational signature predominantly characterized by A→T transversions has been detected in AA-induced UTUC tumor tissues.

The progressive lesions and mutational events initiated by aristolochic acids are irreversible, and no effective therapeutic regimen for AAN and AA-induced UTUC has been established.

Species of Asarum are generally considered to be less toxic than species of Aristolochia. Nevertheless, the FDA warns against consuming Asarum, as it is nephrotoxic and contains the potent carcinogen aristolochic acid.

8.2 Asarone Genotoxicity and Regulatory Limits

Both α-asarone and β-asarone are reported to be genotoxic and hepatocarcinogenic in rodents, with reports of mammalian toxicity and carcinogenicity also noted by the European Medicines Agency (2005). β-asarone is reported to be more toxic than α-asarone.

The European Food Safety Authority (EFSA) evaluated β-asarone in 2002 and recommended maximum levels of 0.1 mg/kg in foods and beverages, with an exceptional limit of 1 mg/kg for alcoholic beverages and seasonings in snack foods, due to its genotoxic and carcinogenic potential in rodents. The genotoxic mechanisms involve metabolic activation to reactive intermediates that form DNA adducts.

In rat hepatocytes, β-asarone is oxidized by cytochrome P450 enzymes to form the electrophilic β-asarone epoxide, which binds to DNA, producing stable adducts. This epoxide metabolite is highly mutagenic, as evidenced by positive results in the Ames test using Salmonella typhimurium strain TA100 with S9 metabolic activation, where β-asarone induced up to a 20-fold increase in revertant colonies at concentrations of 172 μg/plate.

An acceptable daily intake (ADI) for nutritional exposure cannot be derived for β-asarone because a genotoxic mechanism of action is assumed.

Due to potential toxic effects of β-asarone, a limit of exposure from herbal products of approximately 2 μg/kg body weight/day has been set temporarily until a full benefit/risk assessment has been carried out by the European Medicines Agency.

8.3 Additional Toxic Constituents

Potentially toxic components in asarum include safrole, methyl eugenol, aristolochic acids, asarone, 3,5-dimethoxytoluene, and benzene derivatives. These components are associated with toxicity in multiple organs, including the central nervous system, kidneys, and liver. Asarum is also considered carcinogenic. Aristolochic acids in asarum have been demonstrated to exhibit significant nephrotoxicity, in addition to mutagenic and carcinogenic effects.

Special attention should be paid to the fact that the volatile oil of Asarum contains a certain proportion of safrole, a List I chemical designated by the US Drug Enforcement Administration.

8.4 Organ-Specific Toxicity

Asarabacca is nephrotoxic and hepatotoxic (containing safrole) and belongs to the Aristolochiaceae family; products should therefore be tested for safrole and aristolochic acid content.

In human studies, exposure to asarones from the herb Acorus calamus — which contains high concentrations of asarones — caused prolonged vomiting in 7 consumers. No equivalent prospective clinical safety studies for A. europaeum specifically have been published.

8.5 FDA and Regulatory Authority Warnings

Since nephrotoxicity and carcinogenicity of aristolochic acids have been recognized, the US Food and Drug Administration and regulatory authorities of some other countries have issued alerts against the use and import of products containing parts of Aristolochia. Despite the host plants having a long history of use in traditional medicine, modern clinical research suggests aristolochic acids cause kidney and liver cancer. The FDA has issued warnings regarding consumption of AA-containing supplements.

8.6 Adulteration and Misidentification

In the Indian market, Valeriana wallichii DC. has been sold as Tagar but in some cases is also sold as Asaroon, representing a clear case of adulteration by replacement of a costly foreign drug with a similar-looking indigenous drug. Some herbs are known to be toxic and, when appropriate, need to be used with care under supervision of qualified practitioners. Labelling of herbal products may not accurately reflect their content, and adverse events or interactions attributed to specific herbs may actually be due to misidentified plants, pharmaceutical drugs, or heavy metals.

References

• Systematic Overview of Aristolochic Acids: Nephrotoxicity, Carcinogenicity, and Underlying Mechanisms — Frontiers in Pharmacology / PMC (2019)
• Systematic Overview of Aristolochic Acids: Nephrotoxicity, Carcinogenicity, and Underlying Mechanisms — PubMed (2019)
• Medicinally Used Asarum Species: High-Resolution LC-MS Analysis of Aristolochic Acid Analogs and In vitro Toxicity Screening in HK-2 Cells — PMC (2017)
• Integrative Transcriptomics and Metabolomics Analyses Provide Hepatotoxicity Mechanisms of Asarum — PMC (2020)
• Hepatotoxic Potential of Asarones: In Vitro Evaluation of Hepatotoxicity and Quantitative Determination in Herbal Products — PMC / Frontiers in Pharmacology (2015)
• Ethno Pharmacology, Phytochemical Analysis, Safety Profile, Prophylactic Aspects, and Therapeutic Potential of Asarum europaeum L. in Unani Medicine — ScienceDirect (2022)
• Ethno-pharmacology of Asaroon (Asarum europaeum L.) with Special Reference to Unani System of Medicine — PubMed / Journal of Complementary and Integrative Medicine (2021)
• Ethno-pharmacology of Asaroon (Asarum europaeum L.) with Special Reference to Unani System of Medicine — De Gruyter (2022)
• The Genus Asarum: A Review on Phytochemistry, Ethnopharmacology, Toxicology and Pharmacokinetics — Journal of Ethnopharmacology, ScienceDirect (2021)
• The Genus Asarum L.: A Phytochemical and Ethnopharmacological Review — Systematic Reviews in Pharmacy
• α-Asarone, β-asarone, and γ-asarone: Current Status of Toxicological Evaluation — Journal of Applied Toxicology / Wiley (2021)
• Effect of Molecular Distillation on the Anti-inflammatory Activity and Neurotoxicity of Asarum Essential Oil — Frontiers in Pharmacology (2023)
• Pharmacokinetic Study of Safrole and Methyl Eugenol after Oral Administration of the Essential Oil Extracts of Asarum in Rats by GC-MS — PMC (2021)
• Beta-Asarone — WHO Food Additives Series 16, JECFA Monograph
• Asarum europaeum — Grokipedia (based on peer-reviewed citations)
• Asarone — Grokipedia (based on peer-reviewed citations)
• Asarum europaeum — Wikipedia (citing primary sources)
• Aristolochic Acid — Wikipedia (citing primary sources)
• Asarum europaeum — Pereira's Elements of Materia Medica and Therapeutics (1854), Henriette's Herbal
• Asarum europaeum — Woodville's Medical Botany, Henriette's Herbal
• Asarum Europaeum — King's American Dispensatory, Henriette's Herbal
• Safety Issues Affecting Chinese Herbs: The Case of Asarum — Institute for Traditional Medicine (ITM Online)
• European Hazelwort (Asarum europaeum) — Blumen und Natur
• Asarum europaeum L. — Botanical Society of Britain and Ireland (BSBI)